Savient Pharmaceuticals, Inc. Reports Fourth Quarter and Year-End 2012 Financial Results
BRIDGEWATER, N.J., March 19, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three months and full year ended December 31, 2012. Savient ended the quarter with approximately $96.3 million in cash and short-term investments, a decrease of $19.9 million for the quarter.